RxDoctor Payments Data

Dominic Andriacchi, DPM

Podiatrist · Chicago Ridge, ILNPI 1588620900

Payments from drug & device makers

$1,239in general payments, 2019–2025

Across 79 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sebela Pharmaceuticals Inc.$776
  • Medimetriks Pharmaceuticals, Inc.$153
  • Royal Biologics, Inc.$119
  • Glenmark Therapeutics Inc.$65
  • Collaborative Care Diagnostics, LLC$48
  • Tactile Systems Technology Inc$38
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$1,239100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sebela Pharmaceuticals Inc.46$776
Medimetriks Pharmaceuticals, Inc.14$153
Royal Biologics, Inc.1$119
Glenmark Therapeutics Inc.11$65
Collaborative Care Diagnostics, LLC1$48
Tactile Systems Technology Inc3$38
Zimmer Biomet1$16
Journey Medical Corporation1$13
Metric Medical Devices, Inc.1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,239 in reported general payments places this provider in the 60th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$120,340
Medicare patients
303
Services billed
1,187

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole125$2,502
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip31$785
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$152
Ibuprofen27$122
Silver Sulfadiazine12$119
Allopurinol26$108
SsdSilver Sulfadiazine11$98

Paid to pharmacies, not to this prescriber.

Other podiatrist in Chicago Ridge

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →